Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Johnson & Johnson

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 18 October 2002:
Vol. 298. no. 5593, p. 513
DOI: 10.1126/science.298.5593.513b
Prev | Table of Contents | Next

ScienceScope

Supporters of the National Institutes of Health (NIH) are worried that new programs could be crippled if legislators don't pass the agency's 2003 budget soon.

Congress did not complete most appropriations bills before the fiscal year ended 30 September, instead approving a series of temporary resolutions to fund agencies at 2002 levels. NIH can stay on track if its budget--slated to complete a 5-year doubling to $27.2 billion--is adopted by mid- December, NIH Director Elias Zerhouni told a House appropriations panel last week. But further delay would force NIH to scale back grants, put off construction projects, and "greatly interfere with" $1.7 billion in new bioterrorism research and vaccine development, Zerhouni said. A delay until March--one worst case scenario--could shrink the number of new grants from about 9850 to 6800, according to some research advocates.

ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)